Gene · 3836
Papers2,991
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,991
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nucleus-specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy. | Exploration (Beijing) | 2022 | 37325502 | PubTator, text mining | PubMed |
| Jietacin Derivative Inhibits TNF-α-Mediated Inflammatory Cytokines Production via Suppression of the NF-κB Pathway in Synovial Cells. | Pharmaceuticals (Basel) | 2022 | 36678502 | PubTator, text mining | PubMed |
| Interplay between swine enteric coronaviruses and host innate immune. | Front Vet Sci | 2022 | 36619958 | PubTator, text mining | PubMed |
| Editorial: Underlying molecular interconnections of the estrogen receptor alpha and associated factors involved in breast cancer development: The way to new therapeutic approaches. | Front Endocrinol (Lausanne) | 2022 | 36619544 | PubTator, text mining | PubMed |
| Prospective mode of action of Ivermectin: SARS-CoV-2. | Eur J Med Chem Rep | 2022 | 36593981 | PubTator, text mining | PubMed |
| Trypanosoma cruzi PARP is enriched in the nucleolus and is present in a thread connecting nuclei during mitosis. | PLoS One | 2022 | 36584038 | PubTator, text mining | PubMed |
| G2/M checkpoint regulation and apoptosis facilitate the nuclear egress of parvoviral capsids. | Front Cell Dev Biol | 2022 | 36568985 | PubTator, text mining | PubMed |
| Cancer informatics analysis indicates high CHAC2 associated with unfavorable prognosis in breast cancer. | Front Oncol | 2022 | 36568153 | PubTator, text mining | PubMed |
| Filoviruses: Innate Immunity, Inflammatory Cell Death, and Cytokines. | Pathogens | 2022 | 36558734 | PubTator, text mining | PubMed |
| Nectins and Nectin-like Molecules in Colorectal Cancer: Role in Diagnostics, Prognostic Values, and Emerging Treatment Options: A Literature Review. | Diagnostics (Basel) | 2022 | 36553083 | PubTator, text mining | PubMed |
| Dual activity inhibition of threonine aspartase 1 by a single bisphosphate ligand. | RSC Adv | 2022 | 36545626 | PubTator, text mining | PubMed |
| Alternative splicing liberates a cryptic cytoplasmic isoform of mitochondrial MECR that antagonizes influenza virus. | PLoS Biol | 2022 | 36542656 | PubTator, text mining | PubMed |
Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer. | EJNMMI Radiopharm Chem | 2022 | 36542157 | PubTator, text mining | PubMed |
| Liver injury induced by COVID 19 treatment - what do we know? | World J Gastroenterol | 2022 | 36533104 | PubTator, text mining | PubMed |
| Deciphering the Binding of the Nuclear Localization Sequence of Myc Protein to the Nuclear Carrier Importin α3. | Int J Mol Sci | 2022 | 36499669 | PubTator, text mining | PubMed |
| Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy. | Mol Neurodegener | 2022 | 36482422 | PubTator, text mining | PubMed |
| The rice blast fungus SR protein 1 regulates alternative splicing with unique mechanisms. | PLoS Pathog | 2022 | 36480554 | PubTator, text mining | PubMed |
| MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation. | J Exp Clin Cancer Res | 2022 | 36476366 | PubTator, text mining | PubMed |
| Non-transport roles of nuclear import receptors: In need of the right balance. | Front Cell Dev Biol | 2022 | 36438555 | PubTator, text mining | PubMed |
| Identification of the Karyopherin Superfamily in Maize and Its Functional Cues in Plant Development. | Int J Mol Sci | 2022 | 36430578 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3836/papers?page=17